Veterinary Medicines

Zobuxa 100 mg tablets for dogs

Not authorised
  • Enrofloxacin
Download as PDF

Product identification

Medicine name:
Zobuxa 100 mg tablets for dogs
Zobuxa 100 mg tablete za pse
Active substance:
  • Enrofloxacin
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Enrofloxacin
    100.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01MA90
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • Slovenia
Package description:
  • (ID2) 100 Tablet: unspecified outer container with 1 Blister (Aluminium) with 100 Tablet
  • (ID1) 10 Tablet: unspecified outer container with 1 Blister (Aluminium) with 10 Tablet

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Elanco GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Elanco France S.A.S.
Responsible authority:
  • Agency For Medicinal Products And Medical Devices Of The Republic Of Slovenia
Authorisation number:
  • DC/V/0375/003
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0197/003

Documents

Summary of Product Characteristics

English (PDF)
Published on: 14/02/2022
Download
Slovenian (PDF)
Published on: 22/02/2022
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Slovenian (PDF)
Published on: 22/02/2022
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Slovenian (PDF)
Published on: 22/02/2022
Download